Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Functional DN for Shortened HS Muscle

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04668092
Recruitment Status : Completed
First Posted : December 16, 2020
Last Update Posted : December 16, 2020
Sponsor:
Information provided by (Responsible Party):
Riphah International University

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The aim of this study is to find whether functional dry needle is helpful to increase the length of shortened hamstring muscle or not

Condition or disease Intervention/treatment Phase
Hamstring Contractures Other: Functional dry needling Not Applicable

Detailed Description:
Single pretest-post clinical trial to find immediate effects of functional dry needling to increase the length of the shortened hamstring. This study will be carried on single group which will include male subjects only. The data will be recorded before and immediately after the treatment. A monofilament stainless steel needle will be inserted on three points on hamstring muscle which will include semitendinosus, semimembranosus and bicep femoris. Treatment session will consist of 1 minute 20 seconds for each point on the hamstring and the manipulation will be performed by "Pistoning technique" in which the needle will be drawn out (not fully out of skin) after inserted and then again pushed in and data will be recorded after the treatment session on the basis of increase in length of hamstring which will be measure through 90-90 SLR (AKE) and on the lower extremity functional scale (LEFS)
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 27 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Masking Description: assessor who helped to record the measurement was blinded
Primary Purpose: Treatment
Official Title: Immediate Effects of Functional Dry Needling on the Length of Shortened Hamstring Muscle
Actual Study Start Date : February 1, 2019
Actual Primary Completion Date : November 20, 2020
Actual Study Completion Date : December 6, 2020
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Functional dry needling
Functional dry needling for shortened hamstring muscle
 Other: Functional dry needling
functional dry needling applied to hamstring for 1 minute and post interventional data collected


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. 90-90 SLR is a test used to measure hamstring length through goniometer.patient lie supine and flex the hip and extend the knee [ Time Frame: 1 day ]
    90-90 SLR


Secondary Outcome Measures :
  1. Lower extremity Functional scale [ Time Frame: 1 day ]
    LEFS is a 20 content scale design to measure the disability level of the patient on the basis of function of the lower extremity


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Male
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Having hamstring length less than 80 degree during 90-90 SLR on goniometer,
  • also the subject that suffers from knee Osteoarthritis,
  • Spondylosis,
  • LBP,
  • Lumber radiculopathy,
  • Subjects with MTrPs and those with hyper lordosis were recruited in the study

Exclusion Criteria:

  • subjects suffering from blood clotting disorders such as hemophilia,
  • those with deformities such as leg length discrepancy,
  • compromised immune system,
  • vascular diseases,
  • Diabetes,
  • People with congenital or metabolic bone disease such as Spondyloepiphyseal Dysplasia and Pregnancy were excluded from the study
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04668092


Locations
Layout table for location information
Pakistan
Saidu group of teaching hospital said sharif swat
Swat, Kpk, Pakistan, 19130
Sponsors and Collaborators
Riphah International University
Investigators
Layout table for investigator information
Principal Investigator: Muhammad Affan Iqbal, Phd* Riphah International University
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Additional Information:

Layout table for additonal information
Responsible Party: Riphah International University
ClinicalTrials.gov Identifier: NCT04668092    
Other Study ID Numbers: REC/00767 Qaisar Ali Khan
First Posted: December 16, 2020    Key Record Dates
Last Update Posted: December 16, 2020
Last Verified: December 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Riphah International University:
Dry needling
LEFS
90-90 SLR
Additional relevant MeSH terms:
Layout table for MeSH terms
Contracture
Joint Diseases
Musculoskeletal Diseases
Muscular Diseases